Bayzed Health Group Inc. published its monthly return for the month ended 28 February 2026. According to the announcement, the total authorized share capital remained at 5,000,000,000 ordinary shares, each with a par value of USD 0.00001, amounting to USD 50,000 in total. No changes were recorded in the authorized or registered share capital during the reporting period.

As of the close of February 2026, the number of issued shares stood at 1,318,466,823, with zero treasury shares. No additional shares were issued, repurchased, or redeemed, and the reported public float continues to meet the applicable 25% threshold. There were no outstanding share options under the listed share option scheme, nor any other arrangements or convertibles in place during the month.

The monthly return was submitted on 03 March 2026, indicating compliance with the required procedures and relevant listing rules.